Related Experiment Video
Updated: Sep 16, 2025

05:30
Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
Published on: August 16, 2011
18.3K
In Vitro and In Vivo Models of Neuroschistosomiasis
1Neurology and Neurophysiology Center, Vienna, Austria.
Methods in Molecular Biology (Clifton, N.J.)
|July 7, 2025
Summary
Animal models are crucial for understanding neuroschistosomiasis (brain and spinal cord schistosomiasis) and developing treatments. Continued research into better models is essential for disease management and eradication.
Area of Science:
- * Neuroparasitology
- * Tropical medicine
- * Neurology
Background:
- * Neuroschistosomiasis is a parasitic infection affecting the nervous system.
- * Understanding its pathophysiology and clinical effects is critical.
- * Various animal models have been employed since 1996.
Purpose of the Study:
- * To review the utility of in vitro and in vivo models for neuroschistosomiasis research.
- * To highlight the progression and types of animal models used.
- * To identify the need for improved models for comprehensive study and intervention development.
Main Methods:
- * Review of existing literature on animal models for neuroschistosomiasis.
- * Analysis of studies utilizing mice (CD1, Swiss, BALB/C, C57), rabbits (New Zealand), and rats (Wistar).
- * Evaluation of model capabilities in studying disease spread, infectivity, and treatment effects.
Main Results:
- * Multiple animal models, including various mouse strains, rabbits, and rats, have been utilized.
- * These models facilitate the investigation of neuroschistosomiasis pathophysiology, clinical manifestations, and immune responses.
- * Current models aid in studying disease spread, infectivity, and potential therapeutic interventions.
Conclusions:
- * Existing animal models provide valuable insights into neuroschistosomiasis.
- * Further development of superior models is necessary for a complete understanding of the infection.
- * Improved models are essential for developing immunotherapies, vaccines, and effective long-term disease management strategies.

